NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 2,505.00
-325.00 (-11.48%)
May 18, 2026, 7:45 AM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 247.66 billion as of May 20, 2026. Its market cap has decreased by -56.09% in one year.
Market Cap
247.66B
Enterprise Value
197.33B
Revenue
94.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,505.00
Market Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 247.66B, a decrease of -96.62%. That is a compound annual growth rate of -48.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 247.66B | -38.98% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 345.93B |
| Helixmith | 333.38B |
| Anterogen.Co.,Ltd. | 316.69B |
| GC Cell | 304.30B |
| BINEX | 296.18B |
| HLB Therapeutics | 275.84B |
| Bioneer | 255.78B |
| EASY BIO,Inc. | 231.90B |